Kansas City Life Insurance (OTCMKTS:KCLI) Posts Earnings Results

Key Points

• Kansas City Life Insurance reported quarterly EPS of $0.10, but showed a negative return on equity (≈−0.01%) and a negative net margin of −7.41%, indicating profitability pressures.
• The stock opened at $32.63 with a market cap of about $315.9 million, a negative P/E of −8.87, and a 52‑week range of $27.45–$36.49 (shares were up ~0.1% on the report).
• Kansas City Life Insurance, founded in 1895, is a publicly traded life insurer offering individual life policies (term, universal, whole life) and fixed annuities across the U.S.

Kansas City Life Insurance (OTCMKTS:KCLI - Get Free Report) posted its quarterly earnings results on Monday. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, Zacks reports. Kansas City Life Insurance had a negative return on equity of 0.01% and a negative net margin of 7.41%.

Kansas City Life Insurance Stock Up 0.1%

Shares of KCLI opened at $32.63 on Tuesday. The stock has a market cap of $315.86 million, a price-to-earnings ratio of -8.87 and a beta of 0.46. Kansas City Life Insurance has a 52 week low of $27.45 and a 52 week high of $36.49. The business has a 50-day simple moving average of $32.89 and a two-hundred day simple moving average of $32.44.

About Kansas City Life Insurance

Kansas City Life Insurance Company, trading under the symbol KCLI, is a publicly held life insurer founded in 1895 and headquartered in Kansas City, Missouri. With more than a century of operations, the company has established itself as a provider of life insurance and retirement products across the United States.

The company's core offerings include individual life insurance policies—term life, universal life and whole life—as well as fixed annuities designed to help clients build and preserve wealth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.